# NIH Reporter #5R01CA257251-05

Targeting CDK6 expression/activity in Ph+ and Ph1-like acute lymphoblastic leukemia (ALL)

**Recipient:** Thomas Jefferson University, Philadelphia, PA, United States

**Award Amount:** $631,337.00
**Ceiling:** $631,337.00

**Awarded:** June 17, 2025

**Identifier:** 5R01CA257251-05

NIH research grant awarded to Thomas Jefferson University for targeting CDK6 in acute lymphoblastic leukemia with a total award amount of $631,337.

### Description

Research grant opportunity from the NIH for projects related to leukemia and cancer therapeutics focusing on targeting CDK6 in leukemia cells using PROTACs.

[View original record](https://reporter.nih.gov/search/IgE1H2ioLUOz0qmA4MDg0Q/project-details/11125897)